Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In this video, I did a 12-month review of my GLP-1 journey
Weng T-Y, Tsai S-YA, Su T-P
Due to their large molecular weight and hydrophilic nature, GLP1 agonists face challenges with oral delivery, including poor and variable gastrointestinal absorption, leading to low bioavailability
Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus
Add Cronometer if detailed nutrition tracking matters to you especially micronutrients that are easy to neglect during rapid weight loss
US$ 25.07
US$ 29.56
US$ 26.97
US$ 25.06
US$ 27.68
US$ 20.81
US$ 29.46
US$ 25.88
US$ 21.83
